The relationship between serum tumor-associated trypsin inhibitor levels and clinicopathological parameters in patients with gastric cancer

Date
2013
Author
DOĞAN, Y
Kemik, Özgür
Sumer, A.
Almalı, Necat
Gurluler, E.
Gures, N.
ADAŞ, GÖKHAN
Purisa, SEVİM
Kemik, A.
TÜZÜN, S
Metadata
Show full item record
Abstract
BACKGROUND: Tumor-associated trypsin inhibitor (TATI) is expressed with trypsinogen in tumors. We studied the clinical-pathologic association and significance of preoperative serum levels of TATI in gastric cancer patients.
URI
http://hdl.handle.net/20.500.12627/125350
Collections